Results 11 to 20 of about 1,626,624 (288)
Serotonin reuptake inhibitors and cardiovascular disease [PDF]
, 2005 Selective serotonin re-uptake inhibiting drugs (SSRIs) are widely used for endogenous depression. In addition to depleting the nerve terminals of serotonin they also lower blood platelet serotonin levels.
Noble, M. +2 more
core +8 more sources
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors [PDF]
Neuropsychiatric Disease and Treatment, 2010 Mike Briley, Chantal MoretNeuroBiz Consulting and Communication, Castres, FranceAbstract: Depression is a disabling condition resulting in significant impairment in social functioning, involving the patient’s family, friends, work colleagues ...
Mike Briley, Chantal Moret
doaj +2 more sources
Selective serotonin reuptake inhibitors pathway [PDF]
Pharmacogenetics and Genomics, 2009 Serotonin (5-hydroxytryptamine, 5-HT) is a neurotransmitter that influences multiple processes, including autonomic function, motor activity, hormone secretion, cognition, and complex processes associated with affection, emotion, and reward [1]. In the terminal axon of the serotonergic neuron, free tryptophan (TRP) is converted to 5-HT [2].
Katrin, Sangkuhl +2 more
openaire +2 more sources
The pharmacogenomics of selective serotonin reuptake inhibitors [PDF]
The Pharmacogenomics Journal, 2004 The introduction of selective serotonin (5-HT) reuptake inhibitors (SSRIs) has significantly improved the pharmacological treatment of a range of psychiatric disorders. Nevertheless, despite the undoubted advantages of antidepressant treatment in terms of improved tolerability to therapy while maintaining a high level of efficacy, not all patients ...
SERRETTI, ALESSANDRO, Artioli P.
openaire +3 more sources
Selective serotonin reuptake inhibitors and myocardial infarction [PDF]
ACC Current Journal Review, 2001 Background Depression is an independent risk factor for myocardial infarction (MI). Selective serotonin reuptake inhibitors (SSRIs) may reduce this risk through attenuation of serotonin-mediated platelet activation in addition to ...
W H, Sauer, J A, Berlin, S E, Kimmel
openaire +3 more sources
Antidepressants in pregnancy and breastfeeding [PDF]
, 2007 Copyright © 2007 Australian Prescriber Reproduced with permission from Australian Prescriber The document attached has been archived with permission from the publisher/copyright holder.Maternal depression and anxiety during pregnancy and the early years ...
Anna Sved Williams, Sved-Williams, A.
core +1 more source
Selective serotonin reuptake inhibitors and Alzheimer’s disease
Neural Regeneration Research, 2020 Given the failure to develop disease-modifying therapies for Alzheimer’s disease (AD), strategies aiming at preventing or delaying the onset of the disease are being prioritized. While the debate regarding whether depression is an etiological risk factor
Bernadette Mdawar +2 more
doaj +1 more source
Serotonin Reuptake Inhibitor Increases Pseudarthrosis Rates in Anterior Cervical Discectomy and Fusions [PDF]
Asian Spine Journal, 2023 Study Design Retrospective cohort. Purpose To determine (1) the effects of serotonin reuptake inhibitors in pseudarthrosis rates after anterior cervical decompression and fusion (ACDF) and (2) to identify patient-reported outcome measures in patients ...
Mark James Lambrechts +15 more
doaj +1 more source
The genetics of selective serotonin reuptake inhibitors
Pharmacology & Therapeutics, 2012 Selective serotonin reuptake inhibitors (SSRIs) are among the most widely prescribed drugs in psychiatry. Based on the fact that SSRIs increase extracellular monoamine levels in the brain, the monoamine hypothesis of depression was introduced, postulating that depression is associated with too low serotonin, dopamine and noradrenaline levels.
Kroeze, Y.L. +3 more
openaire +3 more sources
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Hepatology, EarlyView., 2022 Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source